Tildrakizumab for the treatment of exfoliative cheilitis

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Mucosa
Volume:6 Issue:1
Tildrakizumab for the treatment of exfoliative cheilitis

Tildrakizumab for the treatment of exfoliative cheilitis

Authors : Timothy COWAN, Nada ABU ALRUB, Anna WİLSON, Mani MAKHİJA, Dedee MURRELL

Pages : 19-21

Doi:10.33204/mucosa.1209480

View : 23 | Download : 22

Publication Date : 2023-01-31

Article Type : Other Papers

Abstract :Exfoliative cheilitis is an inflammatory condition that can significantly impair quality of life. This is the first reported case of an interleukin-23 inhibitor, tildrakizumab, for the treatment of a chronic, refractory case of exfoliative cheilitis.
Keywords : biyolojik, keilit, tildrakizumab, interlökin 23, dermatoloji

ORIGINAL ARTICLE URL

VIEW PAPER (PDF)

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.

Index of Academic Documents
İzmir Academy Association
CopyRight © 2023-2025